Aparajita Lath Immunization Intellectual Property Pharmaceuticals Public Health Student Fellows Vaccines Is Messenger RNA Patent-Eligible? Read more: Is Messenger RNA Patent-Eligible?
Aparajita Lath Global Health Health Law Policy Intellectual Property Market Design Pharmaceuticals Public Health Reimbursement Resource Allocation Student Fellows Vaccines Unlocking the mRNA Platform Technology: Walking the Talk with Investment Protection Read more: Unlocking the mRNA Platform Technology: Walking the Talk with Investment Protection
Biotechnology Global Health Intellectual Property International Pharmaceuticals Public Health Race Resource Allocation Sarah Gabriele Student Fellows Vaccines Biotech Companies Are Opening Manufacturing Sites in Africa: Will This Help Vaccine Equity? Read more: Biotech Companies Are Opening Manufacturing Sites in Africa: Will This Help Vaccine Equity?
Aparajita Lath Immunization Intellectual Property Pharmaceuticals Public Health Student Fellows Vaccines COVID-19 Vaccine Patent Infringement? The Battle Between Moderna and Pfizer/BioNTech Continues Read more: COVID-19 Vaccine Patent Infringement? The Battle Between Moderna and Pfizer/BioNTech Continues
Bioethics Biotechnology FDA Featured Health Law Policy Human Subjects Research Pharmaceuticals Public Health Sravya Chary Vaccines Challenges in COVID-19 Vaccine Rollout: Lessons from the UK Read more: Challenges in COVID-19 Vaccine Rollout: Lessons from the UK